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Relapsing polychondritis (RP) is a rare, chronic, and potentially fatal multisystemic
inﬂammatory disorder targeting cartilaginous structures. This disorder is fre-
quently associated with rheumatoid arthritis, systemic vasculitis, connective tissue
diseases, and hematologic disorders, but renal involvement is unusual. In the
literature, associated renal pathology includes mesangial expansion, IgA nephro-
pathy, tubulointerstitial nephritis, and segmental necrotizing crescentic glomer-
ulonephritis. We report a case of a 49-year-old male found to have RP and
nephrotic syndrome, with conﬁrmed membranous nephropathy on kidney biopsy.
He responded well to corticosteroids and cyclosporine. This is the ﬁrst case of renal
associated RP conﬁrmed by renal biopsy in Korea. Membranous nephropathy
associated with RP has never before been reported.
& 2012. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Relapsing polychondritis (RP) is a rare autoimmune disease
of unknown etiology, characterized by recurrent inﬂamma-
tory episodes primarily affecting the auricular, nasal or
laryngotracheal cartilage. Other noncartilaginous tissues such
as the ocular, audiovestibular, kidney, and vascular systems
may also be affected. Several reviews of the speciﬁc clinical
manifestations found in RP have been published (ocular,
otorhinolaryngologic, cardiac, and respiratory). Renal involve-
ment has rarely been reported. We treated an unusual case of
a 49-year-old male with nephrotic syndrome diagnosed with
RP. We describe the unique features of this case and provide a
review of the literature on renal-associated RP.rean Society of Nephrology. P
ses/by-nc-nd/4.0/).
gy, Department of Inter-
k University, San 16-5
30-714, Korea.
K Lee).Case report
A 49-year-old man was admitted to our hospital in June
2010, with a 1-month history of generalized edema, weight
gain, and dyspnea on exertion. His past medical history was
signiﬁcant for diabetes mellitus and hypertension for 12 years.
Additionally, he was diagnosed with RP 9 months earlier, in
September 2009, after presenting with recurrent scleritis, bilat-
eral auricular chondritis, and nasal chondritis. He had been on
corticosteroid therapy for RP, but discontinued his medications
4 months prior to admission. On physical examination, his blood
pressure was 130/80 mmHg, pulse was 78 beats/minute and
body temperature was 36.4 1C. His left eye was injected. He had
a notable saddle nose and auricular distortion (Fig. 1A–C). Both
legs showed gross edema.
Laboratory ﬁndings consisted of blood urea nitrogen 15.1
mg/dL, creatinine 0.68 mg/dL, and serum albumin 1.2 g/dL.
Urinalysis showed 3þ proteinuria and urine microscopy was
unremarkable. A spot ﬁrst morning urine protein-to-creatinine
ratio was 13.23 (spot urine P/C, normal o 0.2 g/g), consistentublished by Elsevier. This is an open access article under the CC BY-NC-
Figure 1. Clinical ﬁndings compatible with the diagnostic criteria for relapsing polychondritis. (A) Red conjunctiva and opaque cornea caused by
repeated keratoconjunctivitis. (B) Saddle nose deformity caused by repeated nasal chondritis. (C) Deformed auricle caused by repeated auricular
chondritis.
Figure 2. Light microscopy. Capillary basement membranes of rela-
tively normal thickness are shown (silver methenamine; magniﬁcation
 400).
Figure 3. Immunoﬂuorescence microscopy. Granular ﬂuorescence
and IgG deposits in the basement membrane are shown (magniﬁcation
 400).
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including complement factors C3 and C4, antinuclear antibodies,
cryoglobulins, anti-dsDNA antibodies, and perinuclear/cytoplas-
mic anti-neutrophil cytoplasm antibodies, were negative or
normal. Chest X-ray showed hypervolemia, with bilateral pleural
effusion.
At that time, the necessity of a renal biopsy remained unclear,
as the patient’s proteinuria could have resulted from diabeticnephropathy in the setting of a longstanding history of diabetes
mellitus. However, ophthalmic examination revealed no evidence
of diabetic retinopathy, only episcleritis, for which prednisone
was initiated. Our medical team recommended performing a
renal biopsy, but the patient and his family refused. In the
interim, diuretics and antihypertensive medications, including
an angiotensin receptor blocker, were prescribed. In the out-
patient setting, his proteinuria increased (from 8.4 to 26.8 on spot
Kidney Res Clin Pract 31 (2012) 253–256 255urine P/C) as his doses of prednisolone decreased (from 40mg to
5mg). We again recommended a renal biopsy, explaining to the
patient that his proteinuria could be associated with RP. He was
readmitted 9 months after his ﬁrst admission to nephrology,
in March 2011. His AM spot urine P/C ratio was 21.6 at
that time. Percutaneous renal biopsy of the left kidney,
performed under ultrasound guidance, showed nine glomer-
uli. Capillary basement membranes, of relatively normal
thickness, were observed on light microscopy (Fig. 2).
Direct immunoﬂuorescence studies demonstrated the presence
of IgG in a granular fashion along the basement membrane
(Fig. 3). Ultrastructural studies revealed electron-dense deposits
in the subepithelium (Fig. 4). Although they also showed focal
mesangial expansion and nonspeciﬁc capillary wall thickening
(Figure not shown), which could be consistent with the ﬁndings
of early stage of diabetic nephropathy, we did not think these
were the main lesions causing the massive proteinuria in the
patient. The patient responded well to prednisolone (1 mg/kg/
day), which was later tapered, due to a concern about iatrogenic
Cushing disease and long-term complications of using high dose
steroids. Cyclosporine (3 mg/kg) was initiated to when the
steroid was tapered. At an 18-month follow-up visit, the patient
continued to respond well to cyclosporine (150 mg bid) and low
dose prednisolone (10 mg/day). No relapse was observed during
this follow-up (spot urine P/C 0.6, serum creatinine 0.82 mg/dL
in September 2012). The patient’s progress was summarized in
Table 1.Figure 4. Electron microscopy. Electron-dense deposits in the sub-
epithelial locations are shown (magniﬁcation 5850).
Table 1. Laboratory data according to date, events and immunosuppre
Date Events/immunosuppressants
(dose: mg/day)
sCr
(m
Sep 2009 RP diagnosed 0.5
Jun 2010 Nephrotic syndrome developed 0.6
Jul 2010 Episcleritis/ PD 40 0.9
Oct 2010 PD 5 1.1
Mar 2011 Kidney biopsy/starting PD 60 1.0
Aug 2011 Starting CPN 150 bid þ tapering PD 0.8
Sep 2012 CPN 150 bid þ PD 10 0.8
CPN, cyclosporine; NA, not available; PD, prednisolone; RP, relapsing poly
concentration; spot urine P/C, spot urine protein/creatinine ratio; UA, urinDiscussion
RP is a rare autoimmune disease, characterized by recur-
rent bouts of inﬂammation and permanent destruction of
cartilaginous structures such as the ears, nose, joints, trachea,
and larynx. Other tissues high in glycosaminoglycans, such as
the heart, blood vessels, inner ear, cornea, and sclera, can also
be affected [1]. As RP is a clinically diagnosed entity, there
are no speciﬁc laboratory tests available to establish the
diagnosis. The diagnostic criteria have been described by
McAdam et al [1]. Our patient fulﬁlled these criteria, having
recurrent auricular chondritis, hearing loss, nasal chondritis,
respiratory tract chondritis, and ocular inﬂammation.
Renal complications of RP are rare. About 22% of patients
with RP develop some type of renal lesion with microhema-
turia, proteinuria, or abnormal kidney biopsies [2]. Chang-
Miller et al described patients with renal involvement as
having worse survival outcomes and an increased frequency
of extrarenal vasculitis and arthritis in comparison to RP
patients without renal involvement [2]. Biopsy-proven
nephropathy has been reported in o 10 cases [3] and has
never been reported in Korea. Renal pathology may manifest
as mesangial expansion, IgA nephropathy, tubulointerstitial
nephritis, segmental necrotizing crescentic glomerulonephri-
tis, and minimal change disease [3]. In previous reports [2,3],
immunoﬂuorescence microscopy of kidney biopsy specimens
inconstantly shows IgA, IgG, IgM and complement deposits in
the basement membrane, capillary walls and mesangium,
suggesting that immune complexes may play a role in the
pathogenesis of the glomerular lesions of RP. We think this
may also be the main pathogenetic factor of our case.
As far as we know, this is the ﬁrst case of membranous
nephropathy associated with RP ever reported.
Our delay in diagnosis stemmed from the patient’s 12-year
history of diabetes and his reluctance to undergo an invasive
procedure. Eventually, a renal biopsy was performed for the
following reasons: (1) there was no identiﬁable diabetic retino-
pathy; and (2) the amount of proteinuria responded to increased
doses of prednisolone prescribed by his ophthalmologist.
Treatment of RP consists of empiric trials based on clinical
presentations. Because of the rarity of the disease, no clinical
trials have been performed. Nonsteroidal antiinﬂammatory
drugs (NSAIDs) alone are adequate for patients with mild
auricular or nasal chondritis. More serious manifestations
require corticosteroids, either oral (0.5–1 mg/kg/day) or intra-
venous pulse therapy in doses of 1000 mg/day. Various immu-
nosuppressive agents, such as cyclophosphamide, azathioprine,
methotrexate, cyclosporine, chlorambucil, and others, have beenssants
g/dL)
UA protein Spot urine
P/C (g/g)
sAlb
(g/dL)
7 – N A 3.8
7 3þ 13.2 1.2
6 3þ 8.4 2.0
6 3þ 26.8 1.7
6 3þ 21.6 1.8
6 1þ 1.7 3.5
2 7 0.6 3.8
chondritis; sAlb, serum albumin concentration; sCr, serum creatinine
alysis.
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unresponsive to conventional immunosuppressive agents [2–4].
Our patient responded dramatically to prednisolone (1 mg/
kg/day), but we had to decrease the steroid dose and instead
add cyclosporine (3 mg/kg) to prevent long-term complications
of high dose prednisolone, which was prescribed for ophthal-
mologic and respiratory manifestations. Currently, he has con-
tinued to do well on low-dose oral corticosteroids (prednisolone
10 mg/day) and cyclosporine (150 mg bid/day, 3 mg/kg/day)
without relapse during an 18-month follow up period.
RP is an intermittent, but progressive disease. Common
causes of death include airway or cardiovascular complica-
tions, secondary infection, renal failure, or systemic vasculitis.
The survival rate was initially reported to be 70% at 4 years [5],
but with the advent of newer and better immunomodulatory
therapeutics, it has now been reported to be 94% at 8 years [6].
In summary, a 49-year-old male patient was diagnosed
with RP 3 years prior to presentation and subsequently
developed nephrotic syndrome 9 months later. He had been
hospitalized for respiratory complications several times
before a renal biopsy was performed. He was diagnosed with
membranous nephropathy associated with RP. High dose
corticosteroid and cyclosporine were prescribed initially and
the patient was maintained on a low dose of prednisolone
and cyclosporine without relapse. In view of the potentiallyprogressive nature of glomerular disease with RP, renal status
should be investigated in all patients with RP.Conﬂict of interest
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